Posted in | News | Light / Image Sensor

FUJIFILM VisualSonics to Highlight One-Touch Pre-Clinical Imaging Platform at World Molecular Imaging Congress Annual Meeting

FUJIFILM VisualSonics Inc., a world leader in real time, in vivo, high-resolution micro-imaging systems designed specifically for pre-clinical research and subsidiary of FUJIFILM SonoSite, Inc., will unveil the world’s first one-touch pre-clinical imaging platform, the Vevo® 3100 on September 17 -20 at the World Molecular Imaging Congress Annual Meeting in Seoul, Korea.

“Equipped with new Vevo HD Image Technology, a customizable touchscreen user interface, and onboard learning, the Vevo® 3100 imaging platform allows researchers to experience a new and efficient method of imaging in the pre-clinical research world,” said Naohiro Fujitani, President & CEO, FUJIFILM SonoSite, Inc. “As the undisputed leader in real-time in vivo micro-imaging systems, FUJIFILM VisualSonics once again advances the world of pre-clinical research with the launch of the Vevo® 3100 imaging platform.”

Touch technology on the Vevo® 3100 imaging platform offers the ultimate preclinical imaging experience in medical research. The unique, gesture-driven user interface can be personalized by multiple users and is easily controlled with the glide of a finger and without keys or buttons. Its intuitive control panel allows customizable workflow for rapid data acquisition, providing extremely high throughput when needed.

The simplicity encourages novice and advanced users alike to attain high quality images provided with the new Vevo HD Image Technology equipped on the system. This real-time image processing algorithm allows researchers to visualize high-resolution data like never before. It reduces speckle noise and artifacts in images while preserving and enhancing critical tissue information. The innovative platform also combines real-time learning with onboard step-by-step imaging tutorials and guides.

With smart engineering and a minimalist design, the Vevo® 3100 has a reduced foot print and weight by 40 percent that encourages portability and navigation of this capital instrument in high traffic and unique research environments to conduct ground breaking science. Lightweight ergonomically designed MX series transducers, are also available and are custom-designed and optimized to operate in harmony with the Vevo® 3100 imaging system. The transducers are available across a range of frequencies to provide flexibility that is needed for small animal studies.

This revolutionary technology provides researchers with an easy to use imaging modality that allows them to obtain in vivo anatomical, functional, physiological and molecular data simultaneously, all in real-time and with a resolution down to 30 μm.

The Vevo Imaging solutions have witnessed over 1000 peer-reviewed published reports of advancing science and medical research. The future of preclinical imaging research will witness unmatched contributions with the Vevo® 3100 in research on high value diseases. As the trusted leader in real time, in vivo micro-imaging systems, FujiFilm VisualSonics redefines deep tissue imaging for research on disease characterization, therapeutic efficacies and pharmacology.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.